ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Thrombin (Human) Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-13G8743
Home | Market Reports | Health| Pharmacy
Global Thrombin Human Market Insights Forecast to 2028
BUY CHAPTERS

Global Thrombin (Human) Market Research Report 2025

Code: QYRE-Auto-13G8743
Report
January 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Baxter
Amresco
BD Biosciences
Life Technologies Corporation
PromoCell
Sigma-Aldrich Corporation
Vitrolife AB
CSL Limited
Bayer
Grifols S A
Octapharma AG
Shanghai Raas
Hualan Biological
Kedrion S p A

Thrombin (Human) Market Size

The global market for Thrombin (Human) was valued at US$ 585 million in the year 2024 and is projected to reach a revised size of US$ 725 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Thrombin (Human) Market

Thrombin (Human) Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Thrombin (Human), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thrombin (Human).
The Thrombin (Human) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Thrombin (Human) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thrombin (Human) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Thrombin (Human) Market Report

Report Metric Details
Report Name Thrombin (Human) Market
Accounted market size in year US$ 585 million
Forecasted market size in 2031 US$ 725 million
CAGR 3.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 500IU/Vial
  • 1000IU/Vial
  • 2500IU/Vial
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter, AMRESCO Inc, BD Biosciences, Life Technologies Corporation, PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB, CSL, Bayer, Grifols, Octapharma, Shanghai RAAS, Hualan Biological, Kedrion
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Thrombin (Human) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Thrombin (Human) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Thrombin (Human) Market growing?

Ans: The Thrombin (Human) Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Thrombin (Human) Market size in 2031?

Ans: The Thrombin (Human) Market size in 2031 will be US$ 725 million.

Who are the main players in the Thrombin (Human) Market report?

Ans: The main players in the Thrombin (Human) Market are Baxter, AMRESCO Inc, BD Biosciences, Life Technologies Corporation, PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB, CSL, Bayer, Grifols, Octapharma, Shanghai RAAS, Hualan Biological, Kedrion

What are the Application segmentation covered in the Thrombin (Human) Market report?

Ans: The Applications covered in the Thrombin (Human) Market report are Biotechnology, Medicine, Microbiology, Others

What are the Type segmentation covered in the Thrombin (Human) Market report?

Ans: The Types covered in the Thrombin (Human) Market report are 500IU/Vial, 1000IU/Vial, 2500IU/Vial

Recommended Reports

Hemostasis Devices

Coagulation Testing

Thrombin & Factors

1 Thrombin (Human) Market Overview
1.1 Product Definition
1.2 Thrombin (Human) by Type
1.2.1 Global Thrombin (Human) Market Value Comparison by Type (2024 VS 2031)
1.2.2 500IU/Vial
1.2.3 1000IU/Vial
1.2.4 2500IU/Vial
1.3 Thrombin (Human) by Application
1.3.1 Global Thrombin (Human) Market Value by Application (2024 VS 2031)
1.3.2 Biotechnology
1.3.3 Medicine
1.3.4 Microbiology
1.3.5 Others
1.4 Global Thrombin (Human) Market Size Estimates and Forecasts
1.4.1 Global Thrombin (Human) Revenue 2020-2031
1.4.2 Global Thrombin (Human) Sales 2020-2031
1.4.3 Global Thrombin (Human) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Thrombin (Human) Market Competition by Manufacturers
2.1 Global Thrombin (Human) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Thrombin (Human) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Thrombin (Human) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Thrombin (Human), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Thrombin (Human), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Thrombin (Human), Product Type & Application
2.7 Global Key Manufacturers of Thrombin (Human), Date of Enter into This Industry
2.8 Global Thrombin (Human) Market Competitive Situation and Trends
2.8.1 Global Thrombin (Human) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Thrombin (Human) Players Market Share by Revenue
2.8.3 Global Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Thrombin (Human) Market Scenario by Region
3.1 Global Thrombin (Human) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Thrombin (Human) Sales by Region: 2020-2031
3.2.1 Global Thrombin (Human) Sales by Region: 2020-2025
3.2.2 Global Thrombin (Human) Sales by Region: 2026-2031
3.3 Global Thrombin (Human) Revenue by Region: 2020-2031
3.3.1 Global Thrombin (Human) Revenue by Region: 2020-2025
3.3.2 Global Thrombin (Human) Revenue by Region: 2026-2031
3.4 North America Thrombin (Human) Market Facts & Figures by Country
3.4.1 North America Thrombin (Human) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Thrombin (Human) Sales by Country (2020-2031)
3.4.3 North America Thrombin (Human) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Thrombin (Human) Market Facts & Figures by Country
3.5.1 Europe Thrombin (Human) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Thrombin (Human) Sales by Country (2020-2031)
3.5.3 Europe Thrombin (Human) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Thrombin (Human) Market Facts & Figures by Region
3.6.1 Asia Pacific Thrombin (Human) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Thrombin (Human) Sales by Region (2020-2031)
3.6.3 Asia Pacific Thrombin (Human) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Thrombin (Human) Market Facts & Figures by Country
3.7.1 Latin America Thrombin (Human) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Thrombin (Human) Sales by Country (2020-2031)
3.7.3 Latin America Thrombin (Human) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Thrombin (Human) Market Facts & Figures by Country
3.8.1 Middle East and Africa Thrombin (Human) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Thrombin (Human) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Thrombin (Human) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Thrombin (Human) Sales by Type (2020-2031)
4.1.1 Global Thrombin (Human) Sales by Type (2020-2025)
4.1.2 Global Thrombin (Human) Sales by Type (2026-2031)
4.1.3 Global Thrombin (Human) Sales Market Share by Type (2020-2031)
4.2 Global Thrombin (Human) Revenue by Type (2020-2031)
4.2.1 Global Thrombin (Human) Revenue by Type (2020-2025)
4.2.2 Global Thrombin (Human) Revenue by Type (2026-2031)
4.2.3 Global Thrombin (Human) Revenue Market Share by Type (2020-2031)
4.3 Global Thrombin (Human) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Thrombin (Human) Sales by Application (2020-2031)
5.1.1 Global Thrombin (Human) Sales by Application (2020-2025)
5.1.2 Global Thrombin (Human) Sales by Application (2026-2031)
5.1.3 Global Thrombin (Human) Sales Market Share by Application (2020-2031)
5.2 Global Thrombin (Human) Revenue by Application (2020-2031)
5.2.1 Global Thrombin (Human) Revenue by Application (2020-2025)
5.2.2 Global Thrombin (Human) Revenue by Application (2026-2031)
5.2.3 Global Thrombin (Human) Revenue Market Share by Application (2020-2031)
5.3 Global Thrombin (Human) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Thrombin (Human) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 AMRESCO Inc
6.2.1 AMRESCO Inc Company Information
6.2.2 AMRESCO Inc Description and Business Overview
6.2.3 AMRESCO Inc Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AMRESCO Inc Thrombin (Human) Product Portfolio
6.2.5 AMRESCO Inc Recent Developments/Updates
6.3 BD Biosciences
6.3.1 BD Biosciences Company Information
6.3.2 BD Biosciences Description and Business Overview
6.3.3 BD Biosciences Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Biosciences Thrombin (Human) Product Portfolio
6.3.5 BD Biosciences Recent Developments/Updates
6.4 Life Technologies Corporation
6.4.1 Life Technologies Corporation Company Information
6.4.2 Life Technologies Corporation Description and Business Overview
6.4.3 Life Technologies Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Life Technologies Corporation Thrombin (Human) Product Portfolio
6.4.5 Life Technologies Corporation Recent Developments/Updates
6.5 PromoCell GmbH
6.5.1 PromoCell GmbH Company Information
6.5.2 PromoCell GmbH Description and Business Overview
6.5.3 PromoCell GmbH Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 PromoCell GmbH Thrombin (Human) Product Portfolio
6.5.5 PromoCell GmbH Recent Developments/Updates
6.6 Sigma-Aldrich Corporation
6.6.1 Sigma-Aldrich Corporation Company Information
6.6.2 Sigma-Aldrich Corporation Description and Business Overview
6.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sigma-Aldrich Corporation Thrombin (Human) Product Portfolio
6.6.5 Sigma-Aldrich Corporation Recent Developments/Updates
6.7 Vitrolife AB
6.7.1 Vitrolife AB Company Information
6.7.2 Vitrolife AB Description and Business Overview
6.7.3 Vitrolife AB Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Vitrolife AB Thrombin (Human) Product Portfolio
6.7.5 Vitrolife AB Recent Developments/Updates
6.8 CSL
6.8.1 CSL Company Information
6.8.2 CSL Description and Business Overview
6.8.3 CSL Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CSL Thrombin (Human) Product Portfolio
6.8.5 CSL Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Thrombin (Human) Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Grifols
6.10.1 Grifols Company Information
6.10.2 Grifols Description and Business Overview
6.10.3 Grifols Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Grifols Thrombin (Human) Product Portfolio
6.10.5 Grifols Recent Developments/Updates
6.11 Octapharma
6.11.1 Octapharma Company Information
6.11.2 Octapharma Description and Business Overview
6.11.3 Octapharma Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Octapharma Thrombin (Human) Product Portfolio
6.11.5 Octapharma Recent Developments/Updates
6.12 Shanghai RAAS
6.12.1 Shanghai RAAS Company Information
6.12.2 Shanghai RAAS Description and Business Overview
6.12.3 Shanghai RAAS Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai RAAS Thrombin (Human) Product Portfolio
6.12.5 Shanghai RAAS Recent Developments/Updates
6.13 Hualan Biological
6.13.1 Hualan Biological Company Information
6.13.2 Hualan Biological Description and Business Overview
6.13.3 Hualan Biological Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hualan Biological Thrombin (Human) Product Portfolio
6.13.5 Hualan Biological Recent Developments/Updates
6.14 Kedrion
6.14.1 Kedrion Company Information
6.14.2 Kedrion Description and Business Overview
6.14.3 Kedrion Thrombin (Human) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Kedrion Thrombin (Human) Product Portfolio
6.14.5 Kedrion Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Thrombin (Human) Industry Chain Analysis
7.2 Thrombin (Human) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Thrombin (Human) Production Mode & Process Analysis
7.4 Thrombin (Human) Sales and Marketing
7.4.1 Thrombin (Human) Sales Channels
7.4.2 Thrombin (Human) Distributors
7.5 Thrombin (Human) Customer Analysis
8 Thrombin (Human) Market Dynamics
8.1 Thrombin (Human) Industry Trends
8.2 Thrombin (Human) Market Drivers
8.3 Thrombin (Human) Market Challenges
8.4 Thrombin (Human) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Baxter
Amresco
BD Biosciences
Life Technologies Corporation
PromoCell
Sigma-Aldrich Corporation
Vitrolife AB
CSL Limited
Bayer
Grifols S A
Octapharma AG
Shanghai Raas
Hualan Biological
Kedrion S p A
List of Tables
 Table 1. Global Thrombin (Human) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Thrombin (Human) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Thrombin (Human) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Thrombin (Human) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Thrombin (Human) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Thrombin (Human) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Thrombin (Human) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Thrombin (Human) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Thrombin (Human), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Thrombin (Human), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Thrombin (Human), Product Type & Application
 Table 12. Global Key Manufacturers of Thrombin (Human), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Thrombin (Human) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombin (Human) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Thrombin (Human) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Thrombin (Human) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Thrombin (Human) Sales Market Share by Region (2020-2025)
 Table 19. Global Thrombin (Human) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Thrombin (Human) Sales Market Share by Region (2026-2031)
 Table 21. Global Thrombin (Human) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Thrombin (Human) Revenue Market Share by Region (2020-2025)
 Table 23. Global Thrombin (Human) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Thrombin (Human) Revenue Market Share by Region (2026-2031)
 Table 25. North America Thrombin (Human) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Thrombin (Human) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Thrombin (Human) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Thrombin (Human) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Thrombin (Human) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Thrombin (Human) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Thrombin (Human) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Thrombin (Human) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Thrombin (Human) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Thrombin (Human) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Thrombin (Human) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Thrombin (Human) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Thrombin (Human) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Thrombin (Human) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Thrombin (Human) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Thrombin (Human) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Thrombin (Human) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Thrombin (Human) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Thrombin (Human) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Thrombin (Human) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Thrombin (Human) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Thrombin (Human) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Thrombin (Human) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Thrombin (Human) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Thrombin (Human) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Thrombin (Human) Sales (K Units) by Type (2020-2025)
 Table 51. Global Thrombin (Human) Sales (K Units) by Type (2026-2031)
 Table 52. Global Thrombin (Human) Sales Market Share by Type (2020-2025)
 Table 53. Global Thrombin (Human) Sales Market Share by Type (2026-2031)
 Table 54. Global Thrombin (Human) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Thrombin (Human) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Thrombin (Human) Revenue Market Share by Type (2020-2025)
 Table 57. Global Thrombin (Human) Revenue Market Share by Type (2026-2031)
 Table 58. Global Thrombin (Human) Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Thrombin (Human) Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Thrombin (Human) Sales (K Units) by Application (2020-2025)
 Table 61. Global Thrombin (Human) Sales (K Units) by Application (2026-2031)
 Table 62. Global Thrombin (Human) Sales Market Share by Application (2020-2025)
 Table 63. Global Thrombin (Human) Sales Market Share by Application (2026-2031)
 Table 64. Global Thrombin (Human) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Thrombin (Human) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Thrombin (Human) Revenue Market Share by Application (2020-2025)
 Table 67. Global Thrombin (Human) Revenue Market Share by Application (2026-2031)
 Table 68. Global Thrombin (Human) Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Thrombin (Human) Price (USD/Unit) by Application (2026-2031)
 Table 70. Baxter Company Information
 Table 71. Baxter Description and Business Overview
 Table 72. Baxter Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Baxter Thrombin (Human) Product
 Table 74. Baxter Recent Developments/Updates
 Table 75. AMRESCO Inc Company Information
 Table 76. AMRESCO Inc Description and Business Overview
 Table 77. AMRESCO Inc Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. AMRESCO Inc Thrombin (Human) Product
 Table 79. AMRESCO Inc Recent Developments/Updates
 Table 80. BD Biosciences Company Information
 Table 81. BD Biosciences Description and Business Overview
 Table 82. BD Biosciences Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. BD Biosciences Thrombin (Human) Product
 Table 84. BD Biosciences Recent Developments/Updates
 Table 85. Life Technologies Corporation Company Information
 Table 86. Life Technologies Corporation Description and Business Overview
 Table 87. Life Technologies Corporation Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Life Technologies Corporation Thrombin (Human) Product
 Table 89. Life Technologies Corporation Recent Developments/Updates
 Table 90. PromoCell GmbH Company Information
 Table 91. PromoCell GmbH Description and Business Overview
 Table 92. PromoCell GmbH Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. PromoCell GmbH Thrombin (Human) Product
 Table 94. PromoCell GmbH Recent Developments/Updates
 Table 95. Sigma-Aldrich Corporation Company Information
 Table 96. Sigma-Aldrich Corporation Description and Business Overview
 Table 97. Sigma-Aldrich Corporation Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Sigma-Aldrich Corporation Thrombin (Human) Product
 Table 99. Sigma-Aldrich Corporation Recent Developments/Updates
 Table 100. Vitrolife AB Company Information
 Table 101. Vitrolife AB Description and Business Overview
 Table 102. Vitrolife AB Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Vitrolife AB Thrombin (Human) Product
 Table 104. Vitrolife AB Recent Developments/Updates
 Table 105. CSL Company Information
 Table 106. CSL Description and Business Overview
 Table 107. CSL Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. CSL Thrombin (Human) Product
 Table 109. CSL Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Bayer Thrombin (Human) Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. Grifols Company Information
 Table 116. Grifols Description and Business Overview
 Table 117. Grifols Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Grifols Thrombin (Human) Product
 Table 119. Grifols Recent Developments/Updates
 Table 120. Octapharma Company Information
 Table 121. Octapharma Description and Business Overview
 Table 122. Octapharma Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Octapharma Thrombin (Human) Product
 Table 124. Octapharma Recent Developments/Updates
 Table 125. Shanghai RAAS Company Information
 Table 126. Shanghai RAAS Description and Business Overview
 Table 127. Shanghai RAAS Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Shanghai RAAS Thrombin (Human) Product
 Table 129. Shanghai RAAS Recent Developments/Updates
 Table 130. Hualan Biological Company Information
 Table 131. Hualan Biological Description and Business Overview
 Table 132. Hualan Biological Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Hualan Biological Thrombin (Human) Product
 Table 134. Hualan Biological Recent Developments/Updates
 Table 135. Kedrion Company Information
 Table 136. Kedrion Description and Business Overview
 Table 137. Kedrion Thrombin (Human) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Kedrion Thrombin (Human) Product
 Table 139. Kedrion Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Thrombin (Human) Distributors List
 Table 143. Thrombin (Human) Customers List
 Table 144. Thrombin (Human) Market Trends
 Table 145. Thrombin (Human) Market Drivers
 Table 146. Thrombin (Human) Market Challenges
 Table 147. Thrombin (Human) Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Thrombin (Human)
 Figure 2. Global Thrombin (Human) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Thrombin (Human) Market Share by Type: 2024 & 2031
 Figure 4. 500IU/Vial Product Picture
 Figure 5. 1000IU/Vial Product Picture
 Figure 6. 2500IU/Vial Product Picture
 Figure 7. Global Thrombin (Human) Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Thrombin (Human) Market Share by Application: 2024 & 2031
 Figure 9. Biotechnology
 Figure 10. Medicine
 Figure 11. Microbiology
 Figure 12. Others
 Figure 13. Global Thrombin (Human) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Thrombin (Human) Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Thrombin (Human) Sales (2020-2031) & (K Units)
 Figure 16. Global Thrombin (Human) Average Price (USD/Unit) & (2020-2031)
 Figure 17. Thrombin (Human) Report Years Considered
 Figure 18. Thrombin (Human) Sales Share by Manufacturers in 2024
 Figure 19. Global Thrombin (Human) Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Thrombin (Human) Players: Market Share by Revenue in Thrombin (Human) in 2024
 Figure 21. Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Thrombin (Human) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Thrombin (Human) Sales Market Share by Country (2020-2031)
 Figure 24. North America Thrombin (Human) Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Thrombin (Human) Sales Market Share by Country (2020-2031)
 Figure 28. Europe Thrombin (Human) Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Thrombin (Human) Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Thrombin (Human) Revenue Market Share by Region (2020-2031)
 Figure 36. China Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Thrombin (Human) Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Thrombin (Human) Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Thrombin (Human) Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Thrombin (Human) Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Thrombin (Human) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Thrombin (Human) by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Thrombin (Human) by Type (2020-2031)
 Figure 58. Global Thrombin (Human) Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Thrombin (Human) by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Thrombin (Human) by Application (2020-2031)
 Figure 61. Global Thrombin (Human) Price (USD/Unit) by Application (2020-2031)
 Figure 62. Thrombin (Human) Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Thrombus Management Device Market Research Report 2025
Global Blood Coagulation Monitor Market Research Report 2025
Global Thrombin Preparation Market Research Report 2024
Global External Hemostatic Device Market Research Report 2025
Global Hemostasis Analyzer System Market Research Report 2024
Automated Coagulation Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coagulation Filter Market Research Report 2024
4 Channel Coagulometer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Thrombocytes Market Research Report 2025
Global Human Antithrombin III Market Research Report 2024
Global 0 Market Research Report 2024
Global 0 Market Research Report 2024
Global Haemostat Market Research Report 2025
Global Anticoagulation Therapy Devices Market Research Report 2024
Global Coagulase Plasma Market Research Report 2025
Topical Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Healthcare Data Monetization Market Research Report 2025
Global Absorbable Hemostatic Sponge Market Research Report 2024
Global Hemostats Sealants Market Insights Forecast to 2030
Global Commercial Medical Testing Services Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions